Back

Intradiscal propionic acid levels in chronic low back pain patients with Modic type 1 changes are associated with systemic immune cell activation

Devan, J.; Zhou, J.; Wu, P.-H.; Bonheim, N.; ONeill, C.; Lotz, J.; Link, T.; Torres Espin, A.; Dudli, S.; Fields, A. J.

2026-01-06 orthopedics
10.64898/2026.01.06.26343445 medRxiv
Show abstract

BackgroundModic type 1 changes (MC1) are vertebral endplate bone marrow lesions strongly associated with chronic low back pain (CLBP), but their underlying pathobiology remains unclear. Recent findings suggest that disc-bone marrow crosstalk that includes Cutibacterium acnes (C. acnes) infection of the disc, and immune system activation in the adjacent vertebrae may play a significant role. MethodsIn a prospective analysis of patients from the UCSF comeBACK cohort, we quantified intradiscal propionic acid (PA) - a metabolic product of C. acnes - using magnetic resonance spectroscopy (MRS). Patients were stratified into tertiles based on intradiscal PA content, and the uppermost (PA-high) and lowest (PA-low) tertiles were compared for systemic immune signatures, including whole-blood transcriptomics (n=196), flow cytometry immunophenotyping (n=224), and serum cytokine profiling (n=398). ResultsElevated intradiscal PA was associated with distinct systemic immune responses in patients with MC1 but not in patients with Modic type 2 or without Modic changes. Transcriptomic analysis revealed enrichment of adaptive immune pathways and B cell activation signatures in PA-high MC1. Flow cytometry identified the expansion of immunosuppressive ectonucleotidases-expressing B cells in PA-high MC1 patients. Finally, the correlation profiles of intradiscal PA levels and circulating B cells with serum cytokine concentrations were highly similar. Together, these data consistently indicate that systemic B cell activation is a hallmark of PA-high MC1. ConclusionIntradiscal PA, measurable non-invasively by MRS, stratifies MC1 patients into biologically distinct subgroups characterised by systemic B cell activation. These findings suggest a systemic immune component to MC1 pathobiology and highlight B cells as candidate biomarkers and therapeutic targets for MC1-related chronic low back pain.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

1
Arthritis & Rheumatology
33 papers in training set
Top 0.1%
53.6%
50% of probability mass above
2
Scientific Reports
3102 papers in training set
Top 29%
4.1%
3
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.2%
3.7%
4
JCI Insight
241 papers in training set
Top 2%
2.8%
5
BMC Medicine
163 papers in training set
Top 2%
2.4%
6
eBioMedicine
130 papers in training set
Top 0.7%
2.2%
7
PLOS ONE
4510 papers in training set
Top 47%
2.2%
8
Pain
70 papers in training set
Top 0.5%
2.1%
9
The Journal of Pain
26 papers in training set
Top 0.3%
2.1%
10
Arthritis Research & Therapy
15 papers in training set
Top 0.2%
1.8%
11
PLOS Genetics
756 papers in training set
Top 8%
1.8%
12
Nature Communications
4913 papers in training set
Top 54%
1.4%
13
Journal of Clinical Investigation
164 papers in training set
Top 5%
0.9%
14
Science Advances
1098 papers in training set
Top 26%
0.9%
15
Computational and Structural Biotechnology Journal
216 papers in training set
Top 7%
0.9%
16
Osteoarthritis and Cartilage
30 papers in training set
Top 0.3%
0.8%
17
eLife
5422 papers in training set
Top 55%
0.8%
18
eneuro
389 papers in training set
Top 8%
0.8%
19
Frontiers in Immunology
586 papers in training set
Top 8%
0.7%
20
Science Translational Medicine
111 papers in training set
Top 6%
0.7%
21
Cell Reports Medicine
140 papers in training set
Top 10%
0.5%
22
British Journal of Anaesthesia
14 papers in training set
Top 1.0%
0.5%
23
Journal of Clinical Medicine
91 papers in training set
Top 8%
0.5%
24
Frontiers in Endocrinology
53 papers in training set
Top 3%
0.5%